Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure.

Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Claude Daubert J, Sherfesee L, Wells GA, Tang AS.

Eur Heart J. 2013 Dec;34(46):3547-56. doi: 10.1093/eurheartj/eht290. Epub 2013 Jul 29. Review.

2.

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.

Biton Y, Zareba W, Goldenberg I, Klein H, McNitt S, Polonsky B, Moss AJ, Kutyifa V; MADIT‐CRT Executive Committee..

J Am Heart Assoc. 2015 Jun 29;4(7). pii: e002013. doi: 10.1161/JAHA.115.002013.

3.

Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.

Biton Y, Kutyifa V, Cygankiewicz I, Goldenberg I, Klein H, McNitt S, Polonsky B, Ruwald AC, Ruwald MH, Moss AJ, Zareba W.

Circ Heart Fail. 2016 Feb;9(2):e002667. doi: 10.1161/CIRCHEARTFAILURE.115.002667.

4.

Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.

Zusterzeel R, Spatz ES, Curtis JP, Sanders WE, Selzman KA, Piña IL, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Caños DA, Strauss DG.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S4-11. doi: 10.1161/CIRCOUTCOMES.114.001548. Epub 2015 Feb 24.

5.

Cardiac resynchronization therapy and QRS duration: systematic review, meta-analysis, and meta-regression.

Kang SH, Oh IY, Kang DY, Cha MJ, Cho Y, Choi EK, Hahn S, Oh S.

J Korean Med Sci. 2015 Jan;30(1):24-33. doi: 10.3346/jkms.2015.30.1.24. Epub 2014 Dec 23. Review.

6.

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.

Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E; MADIT-CRT Executive Committee..

J Am Coll Cardiol. 2012 Jun 19;59(25):2366-73. doi: 10.1016/j.jacc.2012.01.065.

7.

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ; MADIT-CRT Investigators..

Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.

8.

Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

Gold MR, Thébault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC.

Circulation. 2012 Aug 14;126(7):822-9. doi: 10.1161/CIRCULATIONAHA.112.097709. Epub 2012 Jul 10.

9.

Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.

Shah RM, Patel D, Molnar J, Ellenbogen KA, Koneru JN.

Europace. 2015 Feb;17(2):267-73. doi: 10.1093/europace/euu214. Epub 2014 Aug 27. Review.

PMID:
25164431
10.

The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis.

Stavrakis S, Lazzara R, Thadani U.

J Cardiovasc Electrophysiol. 2012 Feb;23(2):163-8. doi: 10.1111/j.1540-8167.2011.02144.x. Epub 2011 Aug 4.

PMID:
21815961
11.

Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.

Linde C, Curtis AB, Fonarow GC, Lee K, Little W, Tang A, Levya F, Momomura S, Manrodt C, Bergemann T, Cowie MR.

Int J Cardiol. 2016 Jan 1;202:349-55. doi: 10.1016/j.ijcard.2015.09.023. Epub 2015 Sep 21.

12.

Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).

Birnie DH, Ha A, Higginson L, Sidhu K, Green M, Philippon F, Thibault B, Wells G, Tang A.

Circ Heart Fail. 2013 Nov;6(6):1190-8. doi: 10.1161/CIRCHEARTFAILURE.113.000380. Epub 2013 Aug 30.

13.

Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.

Brenyo A, Kutyifa V, Moss AJ, Mathias A, Barsheshet A, Pouleur AC, Knappe D, McNitt S, Polonsky B, Huang DT, Solomon SD, Zareba W, Goldenberg I.

Heart Rhythm. 2013 Aug;10(8):1136-43. doi: 10.1016/j.hrthm.2013.04.013. Epub 2013 May 25.

PMID:
23712031
14.

Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.

Zusterzeel R, Selzman KA, Sanders WE, Caños DA, O'Callaghan KM, Carpenter JL, Piña IL, Strauss DG.

JAMA Intern Med. 2014 Aug;174(8):1340-8. doi: 10.1001/jamainternmed.2014.2717.

PMID:
25090172
15.

QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.

Brenyo A, Rao M, Barsheshet A, Cannom D, Quesada A, McNitt S, Huang DT, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2013 Apr;24(4):442-8. doi: 10.1111/jce.12057. Epub 2012 Dec 17.

PMID:
23252875
16.

Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.

Varma N, Manne M, Nguyen D, He J, Niebauer M, Tchou P.

Heart Rhythm. 2014 Jul;11(7):1139-47. doi: 10.1016/j.hrthm.2014.04.001. Epub 2014 Apr 2.

PMID:
24704570
17.

Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.

Sebag FA, Martins RP, Defaye P, Hidden-Lucet F, Mabo P, Daubert JC, Leclercq C.

J Cardiovasc Electrophysiol. 2012 Nov;23(11):1219-27. doi: 10.1111/j.1540-8167.2012.02376.x. Epub 2012 Jun 14.

PMID:
22697464
18.

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.

Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C; REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group..

Eur Heart J. 2013 Sep;34(33):2592-9. doi: 10.1093/eurheartj/eht160. Epub 2013 May 2.

PMID:
23641006
19.

Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials.

Sohaib SM, Finegold JA, Nijjer SS, Hossain R, Linde C, Levy WC, Sutton R, Kanagaratnam P, Francis DP, Whinnett ZI.

JACC Heart Fail. 2015 Apr;3(4):327-36. doi: 10.1016/j.jchf.2014.11.007. Epub 2015 Mar 11. Review.

PMID:
25770400
20.

Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.

Daimee UA, Moss AJ, Biton Y, Solomon SD, Klein HU, McNitt S, Polonsky B, Zareba W, Goldenberg I, Kutyifa V.

Circ Heart Fail. 2015 Jul;8(4):725-32. doi: 10.1161/CIRCHEARTFAILURE.115.002082. Epub 2015 Jun 2.

Supplemental Content

Support Center